Literature DB >> 11342183

The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens.

N Rothman1, S Wacholder, N E Caporaso, M Garcia-Closas, K Buetow, J F Fraumeni.   

Abstract

Overwhelming evidence indicates that environmental exposures, broadly defined, are responsible for most cancer. There is reason to believe, however, that relatively common polymorphisms in a wide spectrum of genes may modify the effect of these exposures. We discuss the rationale for using common polymorphisms to enhance our understanding of how environmental exposures cause cancer and comment on epidemiologic strategies to assess these effects, including study design, genetic and statistical analysis, and sample size requirements. Special attention is given to sources of potential bias in population studies of gene--environment interactions, including exposure and genotype misclassification and population stratification (i.e., confounding by ethnicity). Nevertheless, by merging epidemiologic and molecular approaches in the twenty-first century, there will be enormous opportunities for unraveling the environmental determinants of cancer. In particular, studies of genetically susceptible subgroups may enable the detection of low levels of risk due to certain common exposures that have eluded traditional epidemiologic methods. Further, by identifying susceptibility genes and their pathways of action, it may be possible to identify previously unsuspected carcinogens. Finally, by gaining a more comprehensive understanding of environmental and genetic risk factors, there should emerge new clinical and public health strategies aimed at preventing and controlling cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342183     DOI: 10.1016/s0304-419x(00)00021-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Pharmacogenetics and pharmacogenomics: recent developments, their clinical relevance and some ethical, social, and legal implications.

Authors:  Paul W Norbert; Allen D Roses
Journal:  J Mol Med (Berl)       Date:  2003-03       Impact factor: 4.599

Review 2.  How much does the environment contribute to cancer?

Authors:  Lesley Rushton
Journal:  Occup Environ Med       Date:  2003-02       Impact factor: 4.402

3.  Public health's response to a changed world: September 11, biological terrorism, and the development of an environmental health tracking network.

Authors:  Susan West Marmagas; Laura Rasar King; Michelle G Chuk
Journal:  Am J Public Health       Date:  2003-08       Impact factor: 9.308

Review 4.  Integrating epidemiology and genetic association: the challenge of gene-environment interaction.

Authors:  Peter Kraft; David Hunter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 5.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

Review 6.  Capitalizing on Mendelian randomization to assess the effects of treatments.

Authors:  George Davey Smith
Journal:  J R Soc Med       Date:  2007-09       Impact factor: 5.344

7.  Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies--challenges and opportunities.

Authors:  Muin J Khoury; Sholom Wacholder
Journal:  Am J Epidemiol       Date:  2008-11-20       Impact factor: 4.897

Review 8.  Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies.

Authors:  Ma'en Obeidat; Ian P Hall
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

9.  CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.

Authors:  Bao-Sheng Wang; Zhen Liu; Wei-Xue Xu; Shao-Long Sun
Journal:  Tumour Biol       Date:  2013-04-13

10.  Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population.

Authors:  Marc Sinotte; François Rousseau; Pierre Ayotte; Eric Dewailly; Caroline Diorio; Yves Giguère; Sylvie Bérubé; Jacques Brisson
Journal:  Endocr Relat Cancer       Date:  2008-08-21       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.